Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
SUMMER INFAN SUMR
6.93%
FEDERAL MOGU FDML
6.24%
NATUS MEDICA BABY
5.55%
NEW ORIENTAL EDU
5.44%

Finally Things Look Up for JPMorgan

by Zacks Equity Research

November 09, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

JPMorgan Chase & Co. ( JPM - Analyst Report ) has ushered in some good news for its investors. In its latest quarterly filings, the company stated that it has received approval to restart share buybacks and the litigation related to Bear Stearns Cos. (acquired in 2008) is now settled and requires court approval.

JPMorgan stated that the Federal Reserve has granted approval to resume its share repurchase program in the first quarter of 2013, following the review of the company’s capital plan. Therefore, JPMorgan will be repurchasing $3 billion worth of shares during the above-mentioned period.

The need to resubmit the capital plan emerged owing to the huge trading loss in JPMorgan’s CIO division in May. Following this, the company temporarily suspended share repurchase program to rebuild its capital levels and meet the stringent regulatory capital.

Another overhang that got resolved is the settlement of a lawsuit that accused Bear Stearns of repackaging and selling residential loans to the investors. The investigation was being conducted by the Securities and Exchange Commission (SEC). Though the settlement deal is subject to the final approval of the District Court, the settlement amount is not disclosed.

The SEC was conducting an inquiry into the allegations against Bear Stearns that claimed that after receiving compensation from the loan originators for failed mortgages, the firm did not transfer the same to a trust that was managing residential mortgage-backed securities (RMBS). The SEC was also probing disclosures made to the investors regarding the renegotiated loans.

We believe the removal of these overhangs will prove to be modestly positive for both the investors and the company. Yet, JPMorgan continues to encounter many other probes and lawsuits from the investors and regulators pertaining to its role during the crisis. Along with these, the company is facing investigations for the trading debacle, its alleged role in rigging the LIBOR rates and for money laundering.

However, based on JPMorgan’s strong fundamentals, we anticipate continued synergies from a reduction in reserves for future losses, business diversification, steadily improving retail banking performance and strong capital position.

JPMorgan currently retains a Zacks #2 Rank, which translates into a short-term Buy rating. However, one of its peers, Bank of America Corporation ( BAC - Analyst Report ) , retains a Zacks #3 Rank (short-term Hold rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.